Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.

Share:
More In Business
Altro Wants to Expand Access to Credit
Altro founder and CEO Michael Broughton shares how his company is bringing both expanded credit access and financial wellness to underserved consumers, plus netting early investments from Tinashe, Quavo, and Jay Z’s Marcy Ventures.
Load More